3Morgan G J.Advances in the biology and treatment of myeloma[J].Bt J Haemator,1999,105(suppl 1):4～6.
4Lust J A,Donovan K A.The role of interleukin-1? In the pathogenesis of multiple myeloma[J].Hemator Oncol Clin north Am,1999,13(6):1117～1125.
5Boccadoro M,Pileri A.Diagnosis and standard treatment of multiple myeloma[J].Hematol Oncol Clin north Am,1997,11(1):111～131.
6Rajkumar S V,Kyle R A.Angiogenesis in multiple myeloma[J].Semin Oncol,2001,28(6):560～564.
7Pruneri G,Ponzoni M,Ferreri A J,et al.Microvessel density,a surrogate marker of angiogenesis,is significantly related to survival in multipole myeloma patients[J].Br J Haematol,2002,118(3):817～820.
8Sezer O,Niemoller K,Kaufmann O,et al.Decrease of bone marrow angiogenesis in myeloma patients achieving a remission after chemotherapy[J].Eur J Haematol,2001,66(4):238～244.
